Featured
FDA approves TYLENOL with Naproxen
FDA-approved first and only OTC fixed‑dose combination of acetaminophen and naproxen sodium, expanding non-opioid options for persistent pain.
From Cost Advantage to Value Advantage: The Next Frontier for Generic Manufacturers
Companies are now better positioned to redesign how they compete and create long‑term value.
Beauty at Walmart gets makeover
Shoppers can currently find Beauty 2.0 in some 150 Walmart stores, with 300 more conversions expected by the end of 2026.
Expect B-T-S shoppers to favor stores
The takeaway for retailers isn’t to shout louder about price. It’s to prove, aisle by aisle, that being in-store still delivers what shoppers need, when they need it.
Walgreens opening new location on Long Island's East End
New store marks a key step in the community and ensures access to essential pharmacy and retail services for residents.
Sharon McCollam to retire from president and CFO role at Albertsons
McCollam will remain with the company in an advisory capacity until the end of the fiscal year, Feb. 27, 2027, to ensure a seamless transition.
Albertsons posts mixed Q1 results, unveils ACI Edge restructuring plan
Changes designed to support faster decision-making, strengthen accountability and enhance customer experience
New Acosta Group Tracker reveals how far grocery dollars go
Research suggests consumers have permanently changed how they shop following the inflation surge.
FDA approves TYLENOL with Naproxen
FDA-approved first and only OTC fixed‑dose combination of acetaminophen and naproxen sodium, expanding non-opioid options for persistent pain.
Future Beauty Brands appoints Heather Wallace CEO
Wallace succeeds Rob Keen and brings more than 20 years of experience in beauty and consumer health.
CHPA marks International Self-Care Day
CHPA said self-care interventions save an estimated 1.3 billion hours and $31.8 billion in healthcare-related costs annually across North America.
Théa, Unither Pharmaceuticals announce industrial partnership around new ophthalmic production unit in Auvergne
Under this agreement, the new production unit. located at the Gannat site (Allier), will be primarily dedicated to the manufacture of Théa’s sterile ophthalmic products.